InvestorsHub Logo
Followers 1
Posts 247
Boards Moderated 0
Alias Born 10/28/2012

Re: Alapis post# 74501

Thursday, 05/23/2013 9:12:03 AM

Thursday, May 23, 2013 9:12:03 AM

Post# of 130503
The lympro time table supports revenue in the next 12-24 months. Whether or not the public perception of the ceo'a actions is good or bad they have still maintained a track record of following through. Testing will be the make or break point here. If lympro continues to be a.viable test platform and manf is found effective in humans we will be very happy from these levels.